This compound is a pharmaceutical intermediate used in the manufacturing of dabigatran. It is characterized by a benzimidazole core with a cyanoaniline substituent and ester functionality.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Dabigatran ethyl ester
pharmaceutical intermediate
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
pharmaceutical raw material
3-bromo-5-(2H-tetrazol-5-yl)pyridine
pharmaceutical intermediate
2-Fluoro-3-iodobenzonitrile
pharmaceutical intermediate
Allyl 3-methoxymorpholine-4-carboxylate
pharmaceutical intermediate
2-Methyl-5-nitropyridine
pharmaceutical intermediate
Dabigatran etexilate mesylate
pharmaceutical raw material
Dabigatran
pharmaceutical raw material
ethyl 3-[[2-[(4-cyanoanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
OZBOESGNDSVMDK-UHFFFAOYSA-N
CCOC(=O)CCN(C1=CC=CC=N1)C(=O)C2=CC3=C(C=C2)N(C(=N3)CNC4=CC=C(C=C4)C#N)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.